Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...

For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

Multiple preservatives that are added to food products to lengthen their shelf life have significant associations with overall cancer development.

Better treatment options have improved survival rates in the U.S., according to a report from the American Cancer Society.

The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...